Unified Patent Court (UPC) analytics are now available. Check here

Get Patent Opposition Report for Sant

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Sant against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3659109Method For Determining At Least One Parameter Associated With An Ophthalmic DeviceESSILORJan 31, 2025
EP3902950A Shrinking MachineRED CARPETOct 17, 2024
EP3837094Device For Supporting At Least One Arm Of A UserOTTOBOCKJun 26, 2024
EP3485890Treatment Of Metabolic Disorders In Canine AnimalsBOEHRINGER INGELHEIM VETMEDICAFeb 9, 2024
EP3504033Device For Supporting At Least One Arm Of A UserOTTOBOCKDec 23, 2023
EP3883603A Vaccine For Protection Against Streptococcus SuisINTERVETSep 19, 2023
EP3035958Porcine Circovirus Type 2 (Pcv2) Subunit VaccineBOEHRINGER INGELHEIM ANIMAL HEALTH USAJul 26, 2023
EP3463360Atropine-Containing Aqueous CompositionNANYANG TECHNOLOGICAL UNIVERSITYMay 31, 2023
EP3473101Isoxazoline Compositions And Their Use As Antiparasitics For FelinesINTERVETFeb 11, 2022
EP2275132Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing ThemBOEHRINGER INGELHEIM ANIMAL HEALTH USADec 2, 2021

Explore Sant's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3463360Aug 31, 2022Atropine-Containing Aqueous Composition2
EP3714877Jan 26, 2022Method And Composition For Treating Ocular Hypertension And Glaucoma3
EP3205334Apr 29, 2020Method And Composition For Treating Ocular Hypertension And Glaucoma1
EP2752488Feb 12, 2020Antisense Design1
EP2772249May 3, 2017Method And Composition For Treating Ocular Hypertension And Glaucoma1